|
Associate Scientist, Chronic Disease, Ottawa Hospital Research Institute
Biographical Sketch
Dr. Gary E. Garber is head of the Division of Infectious Diseases in the Department of Medicine at the University of Ottawa and Ottawa Hospital and professor of Medicine and of Biochemistry Microbiology and Immunology at the University of Ottawa. Dr. Garber is vice-chairman of the Department of Medicine and Chairman of the Ottawa Hospital Corporate Infection Control Committee.
Dr. Garber received his M.D. from the University of Calgary and did his internal medicine training at the University of Toronto and infectious disease training and MRC fellowship at the University of British Columbia. Dr. Garber is a previous president of the Canadian Infectious Disease Society, a founder of the Canadian Association for HIV Research. He is a member of the Ontario Provincial Infectious Disease Advisory Committee (PIDAC)
With over 300 papers and abstracts, Dr. Garber's research interests include the appropriate use of antibiotics and evaluating novel antibiotics and antifungal agents in nosocomial infection
Most Recent Publications
Balfour, L, Cooper, C., Kowal, J., Tasca, G.A., Kane, M., Garber, G. Evaluation of Health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based viral hepatitis clinic. Canadian J Public Health 2004:95(4) 272-277.
Cudmore, S., Delgaty, K., Hayward-McClelland, S., Petrin, D., Garber, G. Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis. Clinical Microbiology Reviews. 2004 Vol 17 No. 4.
Eason, E.L., Wells G. A., Garber G. E., Hopkins M. L. Prophylactic antibiotics for abdominal hysterectomy: indicated for low-risk Canadian patients. Journal of Obstetrics and Gynecology Canada July 2004, Vol 111 695-699.
Hernandez, H., Sariego, I., Garber, G., Delgado, R., Lopez, O., Sarracent, J. Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice. Parasite Immunol. 2004 Vol 26(3) 119-125.
van Burik, J.A., Ratanatharathorn, V., Stephan, D., Miller, C., Lipton, J., Vesole, D., Bunin, N., Wall, A., Hiemenz, J., Satoi, Y., Lee, J., Walsh, T., for the National Institute of Allergy and Infectious Diseases Mycoses Study Group (Incl G. Garber). Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients undergoing Hematopoietic Stem Cell Transplantation. Clin Inf Dis 2004:39 1407- 1416.
Garber, G.E. The laboratory diagnosis of Trichomas vaginalis. Can J Infect Dis Med Microbiol Vol 16 2005.
Laterre, P-F., Garber G., Levy, H., Wunderink, R., Kinasewitz, T., Sollet, J-P., Maki, D., Bates, B., Yan, S., Dhainaut, J-F. Severe Community-Acquired Pneumonia As A Cause of Severe Sepsis: Data from the PROWESS Study. Crit Care Med. 2005: (5) 952-961.
Cudmore S and Garber G. Diagnosis and Treatment of Metronidazole Resistant Trichomonas vaginalis infection. Book Title: Antimicrobial Drug Resistance: Principles and Practice for the Clinic and Bench Publisher Info: eds. Mayers, D., Lerner S., Ouellette M. Sobel, J. Humana Press. 2005.
van Heeswijk, RPG, Bourbeau, M., Seguin, I., Giguere, P., Garber, G., Cameron, D.W. Absence of cicardian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV-1-infected patients. Br J Clin Pharmacol 2005 Vol 59:4 398-404.
van Heeswijk, R.P.G., Bourbeau, M., Seguin, I., Giguere, P., Garber, G.E., Cameron, W., Absence of circadian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV-1-infected patients. Br J Clin Pharmacol 2005:59:4 398-404.
Cooper, CL, Breau, C., Laroche, A., Lee, C., and Garber, G. Clinical outcomes of first antiretroviral regiment in HIV/hepatitis C virus co-infection. HIV Medicine 2006 32-37.
Balfour, L., Cooper, C., Kowal, J., Tasca, GA, Silmerman, A., Kane, M., Garber, G. Depression and cigarette smoking independently contribute to reduced quality of life among Canadians living with hepatitis C. Can J Gastroenterol 2006Vol 20:2 81-86
Cooper, C., Al-Bedwawi, S., Lee, C., Garber, G. Infectious Complication Rate during Interferon-based Hepatitis C Therapy is not Related to Neutropenia. Clin Infect Dis 2006:42 1674-1678.
Louie, T., Peppe, J., Watt, K., Johnson, D., Mohammed, R., Dow, G., Weiss, K., Simon, S., John, J., Garber, G., Chasan-Taber, S., Davidson, D., and the Tolevamer Study Investigator Group. Tolevamer, a Novel Nonantibiotic Polymer, Compared to Vancomycin in the reatment of Mild - Moderately Severe C. difficile-associated Diarrhea. Clin Infect Dis 2006:43; (4) 428:31.
Balfour, L., Kowal, J., Silverman, A., Tasca, G., Angel, J., MacPherson, P., Garber, G., Cooper, C., Cameron, D.W. A randomized controlled psycho-education interventional trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART AIDS Care Vol 18, No. 6 830-838 August 2006.
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
| |
General Campus
(see 
